Page 23 - TD-3-2

Tumor Discovery Volatile organic compounds for cancer screening

of urinary volatile organic compounds to monitor the doi: 10.3390/s18082613
efficacy of pitavastatin treatments on mammary tumor 122. Christiansen A, Davidsen JR, Titlestad I, Vestbo J,
progression over time. Molecules. 2022;27(13):4277.
Baumbach J. A systematic review of breath analysis and
doi: 10.3390/molecules27134277 detection of volatile organic compounds in COPD. J Breath
Res. 2016;10(3):034002.
112. van Vorstenbosch R, Cheng HR, Jonkers D, et al. Systematic
review: Contribution of the gut microbiome to the volatile doi: 10.1088/1752-7155/10/3/034002
metabolic fingerprint of colorectal neoplasia. Metabolites. 123. Bannaga AS, Farrugia A, Arasaradnam RP. Diagnosing
2022;13(1):55.
Inflammatory bowel disease using noninvasive applications
doi: 10.3390/metabo13010055 of volatile organic compounds: A systematic review. Expert
Rev Gastroenterol Hepatol. 2019;13(11):1113-1122.
113. Peng X, Liu M, Dai W, et al. Identification and diagnostic
value of characteristic volatile organic compounds in doi: 10.1080/17474124.2019.1685873
exhaled breath of patients with early stage lung cancer. 124. Grabowska-Polanowska B, Skowron M, Miarka P,
Chin J Clin Thorac Cardio Surg. 2020; 12:1429-1435. Pietrzycka A, Śliwka I. The application of chromatographic
114. Keenan JI, Frizelle FA. Biomarkers to detect early-stage breath analysis in the search of volatile biomarkers of
colorectal cancer. Biomedicines. 2022;10(2):255. chronic kidney disease and coexisting type 2 diabetes
mellitus. J Chromatogr B Analyt Technol Biomed Life Sci.
doi: 10.3390/biomedicines10020255
2017;1060:103-110.
115. Pathak AK, Swargiary K, Kongsawang N, Jitpratak doi: 10.1016/j.jchromb
P, Ajchareeyasoontorn N, Udomkittivorakul J et al.
Recent advances in sensing materials targeting clinical 125. Sinclair E, Walton-Doyle C, Sarkar D, et al. Validating
volatile organic compound (VOC) biomarkers: a review. differential volatilome profiles in Parkinson’s disease. ACS
Biosensors. 2023;13(1):114. Cent Sci. 2021;7(2):300-306.
116. Saorin A, Di Gregorio E, Miolo G, Steffan A, Corona doi: 10.1021/acscentsci.0c01028
G. Emerging role of metabolomics in ovarian cancer 126. Plat VD, Bootsma BT, Neal M, et al. Urinary volatile
diagnosis. Metabolites. 2020;10(10):419. organic compound markers and colorectal anastomotic
doi: 10.3390/metabo10100419 leakage. Colorectal Dis. 2019;21(11):1249-1258.
117. Heinrich-Ramm R, Jakubowski M, Heinzow B, et al. doi: 10.1111/codi.14732
Biological monitoring for exposure to volatile organic 127. Plat VD, van Gaal N, Covington JA, et al. Non-invasive
compounds (VOCs) (IUPAC Recommendations 2000). detection of anastomotic leakage following esophageal
Pure Appl Chem. 2020;72(3):385-436. and pancreatic surgery by urinary analysis. Dig Surg.
doi: 10.1351/pac200072030385 2019;36(2):173-180.
118. St Helen G, Liakoni E, Nardone N, Addo N, Jacob P 3 , doi: 10.1159/000488007
rd
Benowitz NL. Comparison of systemic exposure to toxic 128. Francis NK, Curtis NJ, Salib E, et al. Feasibility of
and/or carcinogenic volatile organic compounds (VOC) perioperative volatile organic compound breath testing
during vaping, smoking, and abstention. Cancer Prev Res for prediction of paralytic ileus following laparoscopic
(Phila). 2020;13(2):153-162. colorectal resection. Colorectal Dis. 2020;22(1):86-94.
doi: 10.1158/1940-6207.CAPR-19-0356 doi: 10.1111/codi.14788
119. Tang Z, Liu Y, Duan Y. Breath analysis: technical 129. Kreuder AE, Buchinger H, Kreuer S, et al. Characterization
developments and challenges in the monitoring of human of propofol in human breath of patients undergoing
exposure to volatile organic compounds. J Chromatogr B anesthesia. Int J Ion Mobility Spectrom. 2011;14(4):167-175.
Analyt Technol Biomed Life Sci. 2015;1002:285-299.
doi: 10.1007/s12127-011-0080-y
doi: 10.1016/j.jchromb.2015.08.041
130. Rondanelli M, Perdoni F, Infantino V, et al. Volatile
120. Schmidt K, Podmore I. Current challenges in volatile organic compounds as biomarkers of gastrointestinal
organic compounds analysis as potential biomarkers of diseases and nutritional status. J Anal Methods Chem.
cancer. J Biomark. 2015;2015:981458. 2019;2019:7247802.
doi: 10.1155/2015/981458 doi: 10.1155/2019/7247802
121. Wilson AD. Application of electronic-nose technologies 131. Hageman JHJ, Nieuwenhuizen AG, Ruth SM, et al.
and VOC-biomarkers for the noninvasive early diagnosis of Application of volatile organic compound analysis
gastrointestinal diseases. Sensors (Basel). 2018;18(8):2613. in a nutritional intervention study: Differential

Volume 3 Issue 2 (2024) 17 doi: 10.36922/td.2061